申请人:Boehringer Ingelheim GmbH
公开号:US04137313A1
公开(公告)日:1979-01-30
Compounds of the formula ##STR1## WHEREIN R.sub.1 is hydrogen, methyl or ethyl; R.sub.2 is methyl or ethyl; Y is hydrogen, fluorine, chlorine, bromine, methoxy, methyl, ethyl or trifluoromethyl; and Ar is 2-thiazolyl which may have one or two methyl or ethyl substituents attached thereto; 5,6-dihydro-4H-cyclopentathiazol-2-yl; 4,5,6,7-tetrahydro-2-benzothiazolyl; 2-benzothiazolyl; 3-isothiazolyl which may have a methyl substituent attached thereto; 2-pyridyl which may have a methyl or hydroxyl substituent attached thereto; 3-pyridyl; 4-pyridyl; 4-pyrimidinyl; pyrazinyl; 2-benzimidazolyl; 2-oxazolyl which may have a methyl substituent attached thereto; 2-benzoxazolyl; or phenyl which may have a fluoro, chloro, bromo, methyl, ethyl, trifluoromethyl or methoxy substituent attached thereto; and non-toxic, pharmacologically acceptable salts thereof formed with inorganic or organic bases. The compounds as well as their salts are useful as antiphlogistics and blood platelet aggregation inhibitors.
式为 ##STR1## 的化合物,其中 R.sub.1 是氢、甲基或乙基;R.sub.2 是甲基或乙基;Y 是氢、氟、氯、溴、甲氧基、甲基、乙基或三氟甲基;Ar 是2-噻唑基,可能具有一个或两个连接的甲基或乙基取代基;5,6-二氢-4H-环戊噻唑-2-基;4,5,6,7-四氢-2-苯并噻唑基;2-苯并噻唑基;3-异噻唑基,可能具有一个连接的甲基取代基;2-吡啶基,可能具有一个连接的甲基或羟基取代基;3-吡啶基;4-吡啶基;4-吡咪啶基;吡嗪基;2-苯并咪唑基;2-噁唑基,可能具有一个连接的甲基取代基;2-苯并噁唑基;或苯基,可能具有一个氟、氯、溴、甲基、乙基、三氟甲基或甲氧基取代基;以及与无机或有机碱形成的非毒性、药理学上可接受的盐。这些化合物及其盐可用作抗炎药和血小板聚集抑制剂。